PPAR-δ in Vascular Pathophysiology

PPAR-δ in Vascular Pathophysiology

Peroxisome proliferator-activated receptors belong to the superfamily of ligand-dependent nuclear receptor transcription factors, which include three subtypes: PPAR-α, β/δ, and γ. PPAR-δ, play important roles in the regulation of cell growth and differentiation as well as tissue wound and repair. Em...

Full description

Saved in:

Bibliographic Details
Main Author:	Nanping Wang
Format:	Article
Language:	English
Published:	Wiley 2008-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2008/164163
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

Pathophysiology of Vascular Remodeling in Hypertension
by: Nicolás F. Renna, et al.
Published: (2013-01-01)

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
by: Wojciech G. Garbacz, et al.
Published: (2015-01-01)

Pathophysiological and Genetic Aspects of Vascular Calcification
by: Luis Fernando Escobar Guzman, et al.
Published: (2020-01-01)

Hypertension in Metabolic Syndrome: Vascular Pathophysiology
by: Yolanda Mendizábal, et al.
Published: (2013-01-01)

A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis
by: Rolf Müller, et al.
Published: (2008-01-01)

Dilating Vascular Diseases: Pathophysiology and Clinical Aspects
by: Ertan Yetkin, et al.
Published: (2018-01-01)

Pathophysiology of Headaches with a Prominent Vascular Component
by: Juan A Pareja, et al.
Published: (1996-01-01)

Emerging Role of PPAR-β/δ in Inflammatory Process Associated to Experimental Periodontitis
by: Rosanna Di Paola, et al.
Published: (2011-01-01)

Cinnamic acid alleviates endothelial dysfunction and oxidative stress by targeting PPARδ in obesity and diabetes
by: Yizhen Bai, et al.
Published: (2025-01-01)

Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS
by: Zhigang Zhao, et al.
Published: (2011-01-01)

Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions
by: Yong-Jik Lee, et al.
Published: (2017-01-01)

Cardiomyocyte-Restricted Deletion of PPARβ/δ in PPARα-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation
by: Jian Liu, et al.
Published: (2011-01-01)

δ-Small Submodules and δ-Supplemented Modules
by: Yongduo Wang
Published: (2007-01-01)

Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
by: Cheng-Chia Tsai, et al.
Published: (2014-01-01)

Stimulation of Alpha1-Adrenergic Receptor Ameliorates Cellular Functions of Multiorgans beyond Vasomotion through PPARδ
by: Yong-Jik Lee, et al.
Published: (2020-01-01)

The PPARδ Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells
by: Jordan Clark, et al.
Published: (2009-01-01)

TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ Upregulation
by: Feng Gao, et al.
Published: (2014-01-01)

Pathophysiology /
by: Copstead, Lee Ellen
Published: (2013)

Atherogenic ω-6 Lipids Modulate PPAR- EGR-1 Crosstalk in Vascular Cells
by: Jia Fei, et al.
Published: (2011-01-01)

Pathophysiology : study guide /
by: Banasik, Jacquelyn L.
Published: (2014)

Peroxisome Proliferator-Activated Receptor γ Regulates the Expression of Lipid Phosphate Phosphohydrolase 1 in Human Vascular Endothelial Cells
by: Yazi Huang, et al.
Published: (2014-01-01)

6-Gingerol Normalizes the Expression of Biomarkers Related to Hypertension via PPARδ in HUVECs, HEK293, and Differentiated 3T3-L1 Cells
by: Yong-Jik Lee, et al.
Published: (2018-01-01)

Pathophysiology : the biologic basis for disease in adults and children /
by: McCance, Kathryn L.
Published: (2014)

Leprosy: An Overview of Pathophysiology
by: Ramesh Marne Bhat, et al.
Published: (2012-01-01)

Les nouveaux marqueurs isotopiques de l’alimentation (δ66Zn, δ44Ca, δ15NAA, δ13CAA) et la diversité des stratégies de subsistance néandertaliennes
by: Klervia Jaouen
Published: (2023-12-01)

Mid-Late Holocene Stalagmite δ18O and δ13C Records in Naduo Cave, Guizhou Province, China
by: Jialu Wang
Published: (2021-01-01)

Diabetic Nephropathy: From Pathophysiology to Treatment
by: Ziyan Shen, et al.
Published: (2017-01-01)

PPARβ/δ Agonism with GW501516 Increases Myotube PGC-1α Content and Reduces BCAA Media Content Independent of Changes in BCAA Catabolic Enzyme Expression
by: Caroline N. Rivera, et al.
Published: (2023-01-01)

Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
by: María Sánchez-Aguilar, et al.
Published: (2019-01-01)

Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
by: Sheryar Afzal, et al.
Published: (2021-01-01)

Narcolepsy: Pathophysiology and Neuropsychological Changes
by: Angela Naumann, et al.
Published: (2003-01-01)

The product of r−k and ∇δ on ℝm
by: C. K. Li
Published: (2000-01-01)

Two Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death
by: Alakananda Basu, et al.
Published: (2010-01-01)

PPARs in Neuroinflammation
by: Paul D. Drew, et al.
Published: (2008-01-01)

Derivations and Deformations of δ-Jordan Lie Supertriple Systems
by: Shengxiang Wang, et al.
Published: (2019-01-01)

Canada’s Contribution to Respiratory Physiology and Pathophysiology
by: Peter T Macklem
Published: (2007-01-01)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
by: John P. F. A. Heesakkers, et al.
Published: (2011-01-01)

Pathophysiology of Portal Hypertension and Esophageal Varices
by: Hitoshi Maruyama, et al.
Published: (2012-01-01)

Physiological and pathophysiological actions of insulin in the liver
by: Naoto Kubota, et al.
Published: (2025-02-01)